These compelling findings collectively suggest that PPI can restore sensitivity to sorafenib in sorafenib-resistant HCC cells, providing further support for the role of GRP78 in regulating tumor invasion, metastasis, and sorafenib resistance in these cells. Here, HSPA5 is linked to hepatocellular carcinoma.